By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cornerstone BioPharma, Inc. 

2000 Regency Parkway, Suite 255

Cary  North Carolina  27511  U.S.A.
Phone: 888-466-6503 or 888-466-6503 Fax:

Cornerstone BioPharma, Inc., located next to North Carolina’s Research Triangle Park, is an emerging specialty pharmaceutical company that is currently focused on the development and commercialization of niche prescription medications in the pain, anti-infective, and respiratory markets. The privately held company owns the rights to a pain product line, three respiratory product lines, and co-promotes the Suprax® antibiotic. Cornerstone is actively engaged in the licensing of additional prescription products in niche markets through acquisitions and strategic partnerships.

For more information, please visit:

Last Updated: 03-14-05

Key Statistics

Ownership: Private

Web Site: Cornerstone BioPharma, Inc.

Company News
Stipulation of Dismissal of Claims by Plaintiff Cornerstone BioPharma, Inc. 7/11/2013 9:57:47 AM
Cornerstone BioPharma, Inc. Announces Completion of Merger with Critical Therapeutics 11/3/2008 9:47:52 AM
Critical Therapeutics, Inc. (CRTX) Announces Stockholder Approvals Related to Merger with Cornerstone BioPharma, Inc. and 10-to-1 Reverse Stock Split 10/31/2008 11:16:58 AM
Critical Therapeutics, Inc. (CRTX) Announces Effectiveness Of Registration Statement For The Proposed Merger With Cornerstone BioPharma, Inc. 10/6/2008 10:53:23 AM
Cornerstone BioPharma, Inc. Welcomes David Price as CFO Price to Help Lead Company Through Transition, Growth 8/21/2008 8:36:49 AM
Critical Therapeutics, Inc. (CRTX) Signs Definitive Agreement to Merge with Cornerstone BioPharma, Inc. 5/2/2008 9:55:27 AM
Lupin Ltd. (LUPN.BO) And Cornerstone BioPharma, Inc. End Drug Deal 12/27/2006 10:52:44 AM
Cornerstone BioPharma, Inc. Appoints Alastair McEwan As CFO10/19/2005 5:12:58 PM
Cornerstone BioPharma, Inc. Names Agencies Of Record10/19/2005 5:12:54 PM
Cornerstone BioPharma, Inc. And Adams Laboratories, Inc. Enter Product Transfer Agreement10/19/2005 5:12:44 PM